inVentiv Health -Transforming Promising Ideas into Commercial Reality
inVentiv Health are currently recruiting for a Principal Statistician to work closely and be solely dedicated to a leading pharmaceutical company. This role is responsible for managing and leading assignments on single or multiple projects.
The role will offer you an opportunity to work as integral part of a global biometric team. In this role you will play a vital role in strengthening the relationship between inVentiv and the sponsor company. Working in this type of close partnership will allow you to see the full life cycle of your clinical research projects and ultimately the potential success of the new drug as it goes to market.
As a Principal Statistician you will act as the core project team lead and be responsible for designing and review of CRF's, development of statistical analysis plans, performing validation and statistical quality checks for data and regular client interaction. It is likely you will have the opportunity to design phase II-III studies across therapeutic areas including oncology, cardiovascular and respiratory.
We are looking for an experienced Statistician with a Bachelor's degree in Statistics who has ideally worked with Phase II-III clinical research studies and who is ready to enrich their experience with this new challenge. We are committed to your development and training, joining inVentiv would offer you the opportunity to progress your career within a market leading and innovative organization
Please contact Lyndsey Jewitt, EMEA Recruiter at for further information. We look forward to receiving your application.
inVentiv Health Clinical is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies. With 6,500 passionate employees supporting clients in more than 70 countries, inVentiv Health Clinical works to accelerate high quality drug development programs of all sizes around the world.
Like you, we are committed to enriching the lives of patients, families, and communities by helping to expedite the quality delivery of our clients' therapies to market.